• E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Revolutions Medical Corporation Moves Forward on a PACS Delivery Platform for Its Breakthrough MRI Software Technologies

Posted on: Monday, 29 October 2007, 12:00 CDT

Revolution Medical Corp. (OTC: RMCP) has given approval for Strategic Product Development, its project design consultant, to sign a binding Letter of Intent with Cambridge Medical Information Corporation, CMIC, to move forward with a picture archival computer system (PACS) delivery platform for its breakthrough MRI software technologies.

"Strategic Product Development, Inc, SPD, is pleased to have negotiated a Letter of Intent with CMIC to validate both the Automatic Segmentation and the Color MRI technologies of Rev Med. These important technologies have the potential to give Rev Med a tremendous advantage in the marketplace," reported Richard Theriault, President of SPD.

"Cambridge Medical Information Corp. is pleased to enter into a Letter of Intent with SPD. This will forward the validation of very promising and important ColorMRI and the related automatic segmentation technologies owned by Rev Med. This LOI represents an excellent synergy for the two companies. CMIC has established relationships and installations of advanced PACS systems with some the most prestigious teaching hospitals in China. Revolutions Medical has promising technology that could have a very significant impact on the Magnetic Resonance Imaging market," said ZQ Chen, President of CMIC.

About Cambridge Medical Information Corporation

CMIC is the developer of the next generation in PACS systems, the zPACS, which is an advanced fully functional PACS system currently in operation at several major international hospitals. The zPACS leverages proprietary search and matching methods that enhance medical professionals access to MRI images.

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.


Source: Business Wire

More News in this Category


Related Articles



Rating: 4.0 / 5 (5 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required